Shell Plc ADR (SHEL) concluded trading on Wednesday at a closing price of $71.73, with 4.35 million shares of worth about $311.77 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 11.17% during that period and on July 09, 2025 the price saw a gain of about 0.66%. Currently the company’s common shares owned by public are about 3.00B shares, out of which, 2.94B shares are available for trading.
Stock saw a price change of 0.76% in past 5 days and over the past one month there was a price change of 5.45%. Year-to-date (YTD), SHEL shares are showing a performance of -2.08% which increased to 14.49% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $58.54 but also hit the highest price of $74.46 during that period. The average intraday trading volume for Shell Plc ADR shares is 4.80 million. The stock is currently trading 0.73% above its 20-day simple moving average (SMA20), while that difference is up 4.96% for SMA50 and it goes to 7.36% higher than SMA200.
Shell Plc ADR (NYSE: SHEL) currently have 3.00B outstanding shares and institutions hold larger chunk of about 13.19% of that.
The stock has a current market capitalization of $211.08B and its 3Y-monthly beta is at 0.42. PE ratio of stock for trailing 12 months is 16.59, while it has posted earnings per share of $4.32 in the same period. Its PEG reads 6.72 and has Quick Ratio of 1.08 while making debt-to-equity ratio of 0.43. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SHEL, volatility over the week remained 1.56% while standing at 1.59% over the month.
Stock’s fiscal year EPS is expected to drop by -16.40% while it is estimated to increase by 9.06% in next year. EPS is likely to shrink at an annualized rate of 2.47% for next 5-years, compared to annual growth of 5.38% made by the stock over the past 5-years.
Coverage by TD Cowen stated Shell Plc ADR (SHEL) stock as a Buy in their note to investors on March 19, 2025, suggesting a price target of $81 for the stock. On January 08, 2025, UBS Upgrade their recommendations, while on January 07, 2025, Morgan Stanley Upgrade their ratings for the stock with a price target of $79.80. Stock get an Outperform rating from Wolfe Research on January 03, 2025.
